erlotinib sandoz 150 mg compresse rivestite con film
sandoz pharmaceuticals ag - erlotinibum - compresse rivestite con film - erlotinibum 150 mg ut erlotinibi hydrochloridum, lactosum monohydricum 143.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidi methacrylici copolymerum a, natrii hydrogenocarbonas, e 171, pro compresso obducto corresp. natrium 1.1 mg. - onkologikum - synthetika
zykadia compresse rivestite con film
novartis pharma schweiz ag - ceritinibum - compresse rivestite con film - ceritinibum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum, povidonum k 30, carmellosum natricum conexum corresp. natrium 0.05 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 132, pro compresso obducto. - onkologikum - synthetika
tafinlar 50 mg capsule rigide
novartis pharma schweiz ag - dabrafenibum - capsule rigide - dabrafenibum 50 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - onkologikum - synthetika
tafinlar 75 mg capsule rigide
novartis pharma schweiz ag - dabrafenibum - capsule rigide - dabrafenibum 75.0 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - onkologikum - synthetika
lenvima 4 mg capsule rigide
eisai pharma ag - lenvatinibum - capsule rigide - lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - onkologikum - synthetika
lenvima 10 mg capsule rigide
eisai pharma ag - lenvatinibum - capsule rigide - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - onkologikum - synthetika
ninlaro 2.3 mg capsule rigide
takeda pharma ag - ixazomibum - capsule rigide - ixazomibum 2.3 mg ut ixazomibi citras, cellulosum microcristallinum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, ammoniae solutio 30 per centum, e 172 (nigrum), pro capsula. - onkologikum - synthetika
ninlaro 3.0 mg capsule rigide
takeda pharma ag - ixazomibum - capsule rigide - ixazomibum 3 mg ut ixazomibi citras, cellulosum microcristallinum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (nigrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, ammoniae solutio 30 per centum, e 172 (nigrum), pro capsula. - onkologikum - synthetika
ninlaro 4.0 mg capsule rigide
takeda pharma ag - ixazomibum - capsule rigide - ixazomibum 4 mg ut ixazomibi citras, cellulosum microcristallinum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, ammoniae solutio 30 per centum, e 172 (nigrum), pro capsula. - onkologikum - synthetika
zejula 100 mg capsule
glaxosmithkline ag - niraparibum - capsule - kapsel: niraparibum 100 mg a niraparibi tosilas monohydricus, colore.: e 133, e 127, e 102, excipiens per la capsula. - onkologikum - synthetika